U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Camp4 Therapeutics Corp (0001736730)
SIC: 2834 - Pharmaceutical Preparations
State location: MA | State of Inc.: DE | Fiscal Year End: 1231
Business Address
ONE KENDALL SQUARE
BUILDING 1400 WEST, 3RD FLOOR
CAMBRIDGE MA 02139
617-651-8867
 Mailing Address
ONE KENDALL SQUARE
BUILDING 1400 WEST, 3RD FLOOR
CAMBRIDGE MA 02139
Ownership Reports from: (Click on owner name to see other issuer holdings for the owner, or CIK for owner filings.)

Owner Filings Transaction Date Type of Owner
WILLIAMS DOUGLAS E 0001184847 2025-03-17 director
Stewart Murray 0001723450 2025-03-17 director
Chee Brian 0001295675 2024-10-15 10 percent owner
SCHULMAN AMY W 0001438226 2024-10-15 10 percent owner
AH Bio Fund IV, L.P. 0001889476 2024-10-15 10 percent owner
AH Equity Partners Bio IV, L.L.C. 0001889898 2024-10-15 10 percent owner
Polaris Partners GP X, L.L.C. 0001910575 2024-10-15 10 percent owner
Polaris Partners X, L.P. 0001910577 2024-10-15 10 percent owner
Northpond Ventures III, LP 0001972690 2024-10-15 10 percent owner
Northpond Ventures III GP, LLC 0002010695 2024-10-15 10 percent owner
Andreessen Marc L 0001160077 2024-10-10 10 percent owner
HOROWITZ BENJAMIN A 0001166586 2024-10-10 10 percent owner
Holtzman Steven H 0001300247 2024-10-10 director
Higgins Michael J 0001478521 2024-10-10 director
Young Richard A 0001490283 2024-10-10 director
Chakravarty Ingo 0001574669 2024-10-10 director
Nashat Amir 0001575843 2024-10-10 director, 10 percent owner
Schwab Andrew J. 0001598549 2024-10-10 director, 10 percent owner
Polaris Partners VII, L.P. 0001611189 2024-10-10 10 percent owner
Polaris Entrepreneurs' Fund VII, L.P. 0001615991 2024-10-10 10 percent owner
AH Equity Partners Bio I, L.L.C. 0001656626 2024-10-10 10 percent owner
AH Bio Fund I, L.P. 0001656629 2024-10-10 10 percent owner
PARMAR KUSH 0001664281 2024-10-10 10 percent owner
Polaris Management Co. VII, L.L.C. 0001678203 2024-10-10 10 percent owner
5AM Ventures VI, L.P. 0001753037 2024-10-10 10 percent owner
Ragan Paula 0001769914 2024-10-10 director
5AM Partners VI, LLC 0001829051 2024-10-10 10 percent owner
5AM Opportunities II, L.P. 0001844401 2024-10-10 10 percent owner
Northpond Ventures GP, LLC 0001867470 2024-10-10 10 percent owner
Northpond Ventures, LP 0001867472 2024-10-10 10 percent owner
Rubin Michael P. 0001867627 2024-10-10 10 percent owner
Northpond Ventures II GP, LLC 0001869114 2024-10-10 10 percent owner
Northpond Ventures II, LP 0001869128 2024-10-10 10 percent owner
5AM Opportunities II (GP), LLC 0001873515 2024-10-10 10 percent owner
Maricich Yuri 0001881045 2024-10-10 officer: Chief Medical Officer
Mandel-Brehm Josh 0001927058 2024-10-10 director, officer: Chief Executive Officer
Boylan James P 0001953094 2024-10-10 director
Enavate Sciences GP, LLC 0001953107 2024-10-10 10 percent owner
Thadhani Ravi I. 0002032665 2024-10-10 director
Bumcrot David 0002033326 2024-10-10 officer: Chief Scientific Officer
Gold Kelly 0002033333 2024-10-10 officer: Chief Financial Officer
Everest Aggregator, LP 0002040426 2024-10-10 10 percent owner


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Reporting Owner Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Owner CIK Security Name
A 2025-04-01   Bumcrot David 4 A-Award --D 45000.0000 45000.0000 1 0002033326 Stock Option (Right to Buy)
A 2025-04-01   Maricich Yuri 4 A-Award --D 80000.0000 80000.0000 1 0001881045 Stock Option (Right to Buy)
A 2025-04-01   Gold Kelly 4 A-Award --D 80000.0000 80000.0000 1 0002033333 Stock Option (Right to Buy)
A 2025-04-01   Mandel-Brehm Josh 4 A-Award --D 160000.0000 160000.0000 1 0001927058 Stock Option (Right to Buy)
A 2025-03-17   WILLIAMS DOUGLAS E 4 A-Award --D 17787.0000 17787.0000 1 0001184847 Stock Option (Right to Buy)
A 2025-03-17   Stewart Murray 4 A-Award --D 17787.0000 17787.0000 1 0001723450 Stock Option (Right to Buy)
D 2024-10-15   Northpond Ventures II GP, LLC 4 C-Conversion --I 5287303.0000 0.0000 5 0001869114 Series B Preferred Stock
D 2024-10-15   Northpond Ventures II GP, LLC 4 C-Conversion --I 11251624.0000 0.0000 4 0001869114 Series A Prime Preferred Stock
A 2024-10-15   Northpond Ventures II GP, LLC 4 P-Purchase --I 763636.0000 763636.0000 3 0001869114 Common Stock
A 2024-10-15   Northpond Ventures II GP, LLC 4 C-Conversion --I 471415.0000 471415.0000 2 0001869114 Common Stock
A 2024-10-15   Northpond Ventures II GP, LLC 4 C-Conversion --I 1003193.0000 1003193.0000 1 0001869114 Common Stock
D 2024-10-15   AH Equity Partners Bio I, L.L.C. 4 C-Conversion --I 679163.0000 0.0000 5 0001656626 Series B Preferred Stock
D 2024-10-15   AH Equity Partners Bio I, L.L.C. 4 C-Conversion --I 15001312.0000 0.0000 4 0001656626 Series A Prime Preferred Stock
A 2024-10-15   AH Equity Partners Bio I, L.L.C. 4 P-Purchase --I 545454.0000 545454.0000 3 0001656626 Common Stock
A 2024-10-15   AH Equity Partners Bio I, L.L.C. 4 P-Purchase --I 181818.0000 1579885.0000 2 0001656626 Common Stock
A 2024-10-15   AH Equity Partners Bio I, L.L.C. 4 C-Conversion --I 1398067.0000 1398067.0000 1 0001656626 Common Stock
D 2024-10-15   Enavate Sciences GP, LLC 4 C-Conversion --I 27166530.0000 0.0000 3 0001953107 Series B Preferred Stock
A 2024-10-15   Enavate Sciences GP, LLC 4 P-Purchase --I 1363636.0000 3785802.0000 2 0001953107 Common Stock
A 2024-10-15   Enavate Sciences GP, LLC 4 C-Conversion --I 2422166.0000 2422166.0000 1 0001953107 Common Stock
D 2024-10-15   5AM Partners VI, LLC 4 C-Conversion --I 3395816.0000 0.0000 6 0001829051 Series B Preferred Stock
D 2024-10-15   5AM Partners VI, LLC 4 C-Conversion --I 4244770.0000 0.0000 5 0001829051 Series B Preferred Stock
D 2024-10-15   5AM Partners VI, LLC 4 C-Conversion --I 15002166.0000 0.0000 4 0001829051 Series A Prime Preferred Stock
A 2024-10-15   5AM Partners VI, LLC 4 P-Purchase --I 909090.0000 2625145.0000 3 0001829051 Common Stock
A 2024-10-15   5AM Partners VI, LLC 4 C-Conversion --I 302770.0000 302770.0000 2 0001829051 Common Stock
A 2024-10-15   5AM Partners VI, LLC 4 C-Conversion --I 1716055.0000 1716055.0000 1 0001829051 Common Stock
D 2024-10-15   Nashat Amir 4 C-Conversion --I 277536.0000 0.0000 9 0001575843 Series B Preferred Stock
D 2024-10-15   Nashat Amir 4 C-Conversion --I 3967234.0000 0.0000 8 0001575843 Series B Preferred Stock
D 2024-10-15   Nashat Amir 4 C-Conversion --I 980829.0000 0.0000 7 0001575843 Series A Prime Preferred Stock
D 2024-10-15   Nashat Amir 4 C-Conversion --I 14020475.0000 0.0000 6 0001575843 Series A Prime Preferred Stock
A 2024-10-15   Nashat Amir 4 P-Purchase --I 909090.0000 909090.0000 5 0001575843 Common Stock
A 2024-10-15   Nashat Amir 4 C-Conversion --I 24745.0000 112193.0000 4 0001575843 Common Stock
A 2024-10-15   Nashat Amir 4 C-Conversion --I 353718.0000 1603779.0000 3 0001575843 Common Stock
A 2024-10-15   Nashat Amir 4 C-Conversion --I 87448.0000 87448.0000 2 0001575843 Common Stock
A 2024-10-15   Nashat Amir 4 C-Conversion --I 1250061.0000 1250061.0000 1 0001575843 Common Stock
D 2024-10-15   Schwab Andrew J. 4 C-Conversion --I 3395816.0000 0.0000 7 0001598549 Series B Preferred Stock
D 2024-10-15   Schwab Andrew J. 4 C-Conversion --I 4244770.0000 0.0000 6 0001598549 Series B Preferred Stock
D 2024-10-15   Schwab Andrew J. 4 C-Conversion --I 15002166.0000 0.0000 5 0001598549 Series A Prime Preferred Stock
A 2024-10-15   Schwab Andrew J. 4 P-Purchase --I 909090.0000 2625145.0000 4 0001598549 Common Stock
A 2024-10-15   Schwab Andrew J. 4 C-Conversion --I 302770.0000 302770.0000 3 0001598549 Common Stock
A 2024-10-15   Schwab Andrew J. 4 C-Conversion --I 378463.0000 1716055.0000 2 0001598549 Common Stock
A 2024-10-15   Schwab Andrew J. 4 C-Conversion --I 1337592.0000 1337592.0000 1 0001598549 Common Stock
D 2024-10-15   Holtzman Steven H 4 C-Conversion --D 100014.0000 0.0000 2 0001300247 Series A Prime Preferred Stock
A 2024-10-15   Holtzman Steven H 4 C-Conversion --D 8917.0000 108946.0000 1 0001300247 Common Stock
D 2024-10-15   Young Richard A 4 C-Conversion --D 100014.0000 0.0000 2 0001490283 Series A Prime Preferred Stock
A 2024-10-15   Young Richard A 4 C-Conversion --D 8917.0000 154859.0000 1 0001490283 Common Stock
D 2024-10-15   Mandel-Brehm Josh 4 C-Conversion --D 6791.0000 0.0000 2 0001927058 Series B Preferred Stock
A 2024-10-15   Mandel-Brehm Josh 4 C-Conversion --D 605.0000 272357.0000 1 0001927058 Common Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 277536.0000 0.0000 9 0001678203 Series B Preferred Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 3967234.0000 0.0000 8 0001678203 Series B Preferred Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 980829.0000 0.0000 7 0001678203 Series A Prime Preferred Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 14020475.0000 0.0000 6 0001678203 Series A Prime Preferred Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A P-Purchase --I 909090.0000 909090.0000 5 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 24745.0000 112193.0000 4 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 353718.0000 1603779.0000 3 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 87448.0000 87448.0000 2 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4/A C-Conversion --I 1250061.0000 1250061.0000 1 0001678203 Common Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 277536.0000 0.0000 9 0001678203 Series B Preferred Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 3967234.0000 0.0000 8 0001678203 Series B Preferred Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 980829.0000 0.0000 7 0001678203 Series A Prime Preferred Stock
D 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 14020475.0000 0.0000 6 0001678203 Series A Prime Preferred Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4 P-Purchase --I 909090.0000 909090.0000 5 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 24745.0000 112193.0000 4 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 353718.0000 1603779.0000 3 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 87448.0000 87448.0000 2 0001678203 Common Stock
A 2024-10-15   Polaris Management Co. VII, L.L.C. 4 C-Conversion --I 1250061.0000 1250061.0000 1 0001678203 Common Stock
- -   WILLIAMS DOUGLAS E 3/A - --D 2501.0000 1 0001184847 Common Stock
- -   Enavate Sciences GP, LLC 3 - --I 1 0001953107 Series B Preferred Stock
- -   Northpond Ventures II GP, LLC 3 - --I 2 0001869114 Series B Preferred Stock
- -   Northpond Ventures II GP, LLC 3 - --I 1 0001869114 Series A Prime Preferred Stock
- -   AH Equity Partners Bio I, L.L.C. 3 - --I 2 0001656626 Series B Preferred Stock
- -   AH Equity Partners Bio I, L.L.C. 3 - --I 1 0001656626 Series A Prime Preferred Stock
- -   5AM Partners VI, LLC 3 - --I 3 0001829051 Series B Preferred Stock
- -   5AM Partners VI, LLC 3 - --I 2 0001829051 Series B Preferred Stock
- -   5AM Partners VI, LLC 3 - --I 1 0001829051 Series A Prime Preferred Stock
- -   Maricich Yuri 3 - --D 1 0001881045 Stock Option (Right to Buy)
- -   Mandel-Brehm Josh 3 - --D 10 0001927058 Stock Option (Right to Buy)
- -   Mandel-Brehm Josh 3 - --D 9 0001927058 Stock Option (Right to Buy)
- -   Mandel-Brehm Josh 3 - --D 8 0001927058 Stock Option (Right to Buy)
- -   Mandel-Brehm Josh 3 - --D 7 0001927058 Stock Option (Right to Buy)
- -   Mandel-Brehm Josh 3 - --D 6 0001927058 Stock Option (Right to Buy)

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016